Program Highlights

The Scientific Committee of the CaReMeLO Conference is currently developing an engaging and diverse program for the second edition of the event. More details will be announced soon.

In the meantime, here are the highlights of the 2025 scientific program:

Friday, 30 May 2025

Day 1

This session covers key innovations in CaReMeLO Syndrome care—advances in kidney and cardiac disease management, the role of obesity treatment, and overcoming primary care challenges.

Explore how SGLT2 inhibitors are transforming kidney, cardiac, and metabolic care, and their practical impact on managing CaReMeLO Syndrome.

Engage in discussions of real patient cases—including heart failure, renal issues, obesity, and liver dysfunction. The session will focus on early detection, optimized treatments, lifestyle management, and the role of key medications.

Examine the complexities of resistant hypertension, focusing on advanced management strategies, treatment optimization, and overcoming barriers to effective blood pressure control.

Discover the latest breakthroughs from 2024 clinical trials, highlighting new evidence that is reshaping care for patients with CaReMeLO Syndrome.

Explore advancements in diabetes prevention, groundbreaking kidney care research, and new therapeutic roles for breakthrough treatments in Obstructive Sleep Apnea (OSA), Osteoarthritis, and Metabolic-Associated Steatohepatitis (MASH).

Dive into key trials shaping heart disease care in CaReMeLO, including reducing ASCVD risk in patients with obesity, breakthroughs in HFpEF management, and improving quality of life for HFpEF patients.

Explore how recent clinical evidence is being applied to enhance real-world care for CaReMeLO patients, focusing on practical strategies to improve outcomes.

Saturday, 31 May 2025

Day 2

Explore best practices and innovations in CaReMeLO care, highlighting the leadership of primary care physicians in Israel, Poland, Central Europe, and Spain.

Discover how team-based approaches are enhancing care quality and outcomes, from empowering family physicians and boosting PCP awareness to effective screening, coordinated care, and leveraging telemedicine for improved patient engagement.

Examine the liver’s role in CaReMeLO, focusing on metabolic drivers of MASH, recent RCT findings on improving liver health, and the benefits of weight loss and systemic risk reduction.

Review a case of a middle-aged patient with diabetes, hypertension, obesity, and MASH. Participate in discussions on therapy initiation and engage in an interactive poll to determine the best treatment path.

 

Explore emerging trends in liver care for CaReMeLO patients, including innovative therapies, new research insights, and strategies for improving patient outcomes.

 

 

Master foundational heart care with an echo workshop, and explore the key pillars of heart failure therapy in CaReMeLO patients.

 

 

 

Discover upcoming innovations and new indications shaping the future of medications for CaReMeLO care.

 

Examine the pivotal role of kidney health in CaReMeLO care, with insights from landmark trials on reducing kidney disease progression, cardiovascular benefits, and practical approaches for integrating these therapies into CKD management.

 

Review a case of a middle-aged patient with CKD, type 2 diabetes, and hypertension. Discuss treatment strategies involving Finerenone and an SGLT2 inhibitor, engage in an interactive poll on treatment sequencing, and explore solutions for challenges like hyperkalemia.

 

Explore emerging therapies for CKD, the integration of Finerenone, SGLT2 inhibitors, and other treatments for personalized care, and the role of multidisciplinary teams in optimizing outcomes for CaReMeLO patients.

 

Friday, 30 May 2025

Day 1

Renal Renaissance: Transforming Kidney Care

Cutting-Edge Strategies for Preventing and Managing Cardiac Disease in CaReMeLO Syndrome

Is Treating Obesity First the Right Approach in CaReMeLO Patients?

Overcoming Primary Care Challenges in Managing CaReMeLO Patients

Real-World Case Studies and Expert Insights on Patients with CaReMeLO symptoms and diseases

- Early Detection Strategies
- Optimized Treatment Regimens
- Lifestyle Management Approaches
- Role of Various Medications

Expanding the Boundaries of Therapeutics: Game-Changing Evidence

- Advancing diabetes prevention strategies
- Revolutionizing nephrology with Semaglutide
- The role of Semaglutide and Tirzepatide in Obstructive Sleep Apnea (OSA), Osteoarthritis, and Metabolic-Associated Steatohepatitis (MASH).

Heart Disease in Focus: Transforming Outcomes in the CaReMeLO Patient

- Reducing ASCVD risk in patients with obesity
- Advancements in Heart Failure with Preserved Ejection Fraction (HFpEF)
- Enhancing function and quality of life in HFpEF patients

Turning Evidence into Practice for the CaReMeLO Patient

Saturday, 31 May 2025

Day 2

Leading the Change - Family Physicians in CaReMeLO

Best Practices and Innovations

Transformative Team-Based Care

- Increasing PCP Awareness and Education
- Community and Patient Outreach
- Effective Screening and Early Detection
- Multidisciplinary Team Approaches
- Coordinated Care Strategies
- Leveraging Telemedicine and Remote Monitoring
- Adhering to Guidelines and Protocols
- Measuring Performance and Improving Quality

Navigating Liver Challenges in CaReMeLO: Integrating Modern Therapies

- The Liver as the Nexus in CaReMeLO Patients
- Case Study: A CaReMeLO Patient with MASH and Multisystem Involvement
- Future Directions in Liver Care for CaReMeLO Patients

Obesity treatment with GLP-1 receptor agonists

The Heart in the Middle of CaReMeLO

- Mastering the Basics including echo workshop
- Pillars of therapy in Heart Failure

The Kidney in the Middle of CaReMeLO

- Why the Kidney is Central to CaReMeLO Care and how to approach its care
- Case Study: Multidisciplinary Management of CKD in CaReMeLO Patients
- Future Directions: Building Integrated Care Models